0001209191-14-071577.txt : 20141126 0001209191-14-071577.hdr.sgml : 20141126 20141126180520 ACCESSION NUMBER: 0001209191-14-071577 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141124 FILED AS OF DATE: 20141126 DATE AS OF CHANGE: 20141126 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYLAN INC. CENTRAL INDEX KEY: 0000069499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251211621 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 MYLAN BOULEVARD CITY: CANONSBURG STATE: PA ZIP: 15317 BUSINESS PHONE: 724-514-1800 MAIL ADDRESS: STREET 1: 1000 MYLAN BOULEVARD CITY: CANONSBURG STATE: PA ZIP: 15317 FORMER COMPANY: FORMER CONFORMED NAME: MYLAN LABORATORIES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: FRM CORP DATE OF NAME CHANGE: 19711003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRESCH HEATHER M CENTRAL INDEX KEY: 0001280753 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09114 FILM NUMBER: 141254642 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE STREET 2: SUITE 400 CITY: CANONSBURG STATE: PA ZIP: 15317 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-11-24 0 0000069499 MYLAN INC. MYL 0001280753 BRESCH HEATHER M 1000 MYLAN BLVD CANONSBURG PA 15317 1 1 0 0 Chief Executive Officer Common Stock 2014-11-24 4 M 0 80222 22.14 A 373640 D Common Stock 2014-11-24 4 S 0 80222 55.8575 D 293418 D Common Stock 2014-11-25 4 M 0 19778 22.14 A 313196 D Common Stock 2014-11-25 4 S 0 19778 55.5612 D 293418 D Common Stock 1157 I By 401(k) Plan Employee Stock Option - Right to Buy 22.14 2014-11-24 4 M 0 80222 0.00 D 2017-01-31 Common Stock 80222 19778 D Employee Stock Option - Right to Buy 22.14 2014-11-25 4 M 0 19778 0.00 D 2017-01-31 Common Stock 19778 0 D Represents the weighted average price of the reporting person's disposition of 80,222 shares in transactions ranging from $55.27 to $56.11. Represents the weighted average price of the reporting person's disposition of 19,778 shares in transactions ranging from $55.32 to $55.83. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1 and 2 to this Form 4. This option exercise and the related sale of the underlying common stock were executed pursuant to a 10b5-1 trading plan dated November 9, 2014. The options vested in four equal annual installments beginning on January 31, 2008. /s/ Bradley L. Wideman, by power of attorney 2014-11-26